A recent Phase 3 study of newly diagnosed glioblastoma (GBM) demonstrated the addition
of tumor treating fields (TTFields) to temozolomide (TMZ) after combined radiation/TMZ …

Objective Half of the people living with HIV (PLWH) with hepatitis C virus (HCV) remain
untreated for HCV. We examined predictors of HCV linkage to care among PLWH and the impact …

Background & Aims Patient navigation interventions can improve health outcomes in
underserved, low-income, and racial and ethnic minority groups, who often experience health …

Stroke is a leading cause of death and disability in the United States. Many patients have
long-term functional deficits after surviving ischemic strokes. Current treatments for stroke-…

In recent years, significant advances have been made in brain–computer interfaces (BCIs)
as a tool to help such patients communicate and physically interact with the world around …

Background: An in silico screen was performed to identify FDA approved drugs that inhibit
SARS-CoV-2 main protease (M pro ), followed by in vitro viral replication assays, and in vivo …

“Tag Team” Glioblastoma Therapy: Results From a Phase 1 Trial of Toca 511 and 5-Fluorocytosine
for Recurrent High-Grade Glio Page 1 ATACH-2 trial.An estimated 41% of the participants in …

Alzheimer disease (AD) is the most common cause of dementia and a leading cause of
morbidity and mortality in the elderly. As life expectancy increases, the incidence of AD is …

Background Baricitinib and dexamethasone have randomised trials supporting their use for
the treatment of patients with COVID-19. We assessed the combination of baricitinib plus …

One of the mechanisms that has an important role in the differentiation of stem cells into more
specialized cell types during embryonic development is the methylation of genomic DNA. …